<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ryu H</submitter><funding>National Eye Institute</funding><funding>NEI NIH HHS</funding><funding>NCRR NIH HHS</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>e50684</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8183414</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(6)</volume><pubmed_abstract>SUMOylation plays a crucial role in regulating diverse cellular processes including ribosome biogenesis. Proteomic analyses and experimental evidence showed that a number of nucleolar proteins involved in ribosome biogenesis are modified by SUMO. However, how these proteins are SUMOylated in cells is less understood. Here, we report that USP36, a nucleolar deubiquitinating enzyme (DUB), promotes nucleolar SUMOylation. Overexpression of USP36 enhances nucleolar SUMOylation, whereas its knockdown or genetic deletion reduces the levels of SUMOylation. USP36 interacts with SUMO2 and Ubc9 and directly mediates SUMOylation in cells and in vitro. We show that USP36 promotes the SUMOylation of the small nucleolar ribonucleoprotein (snoRNP) components Nop58 and Nhp2 in cells and in vitro and their </pubmed_abstract><journal>EMBO reports</journal><pubmed_title>The deubiquitinase USP36 promotes snoRNP group SUMOylation and is essential for ribosome biogenesis.</pubmed_title><pmcid>PMC8183414</pmcid><funding_grant_id>CA069533</funding_grant_id><funding_grant_id>R01 CA160474</funding_grant_id><funding_grant_id>R01 GM130604</funding_grant_id><funding_grant_id>GM130604</funding_grant_id><funding_grant_id>P30 CA069533</funding_grant_id><funding_grant_id>EY010572</funding_grant_id><funding_grant_id>S10 RR025571</funding_grant_id><funding_grant_id>P30 EY010572</funding_grant_id><funding_grant_id>R01 CA186241</funding_grant_id><pubmed_authors>Klimek J</pubmed_authors><pubmed_authors>Azuma Y</pubmed_authors><pubmed_authors>Dai RS</pubmed_authors><pubmed_authors>Ryu H</pubmed_authors><pubmed_authors>Fedorov LM</pubmed_authors><pubmed_authors>Dai MS</pubmed_authors><pubmed_authors>Sun XX</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Sears RC</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Zhu HM</pubmed_authors><pubmed_authors>David L</pubmed_authors></additional><is_claimable>false</is_claimable><name>The deubiquitinase USP36 promotes snoRNP group SUMOylation and is essential for ribosome biogenesis.</name><description>SUMOylation plays a crucial role in regulating diverse cellular processes including ribosome biogenesis. Proteomic analyses and experimental evidence showed that a number of nucleolar proteins involved in ribosome biogenesis are modified by SUMO. However, how these proteins are SUMOylated in cells is less understood. Here, we report that USP36, a nucleolar deubiquitinating enzyme (DUB), promotes nucleolar SUMOylation. Overexpression of USP36 enhances nucleolar SUMOylation, whereas its knockdown or genetic deletion reduces the levels of SUMOylation. USP36 interacts with SUMO2 and Ubc9 and directly mediates SUMOylation in cells and in vitro. We show that USP36 promotes the SUMOylation of the small nucleolar ribonucleoprotein (snoRNP) components Nop58 and Nhp2 in cells and in vitro and their </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jun</publication><modification>2025-04-18T14:13:08.412Z</modification><creation>2025-04-07T00:13:06.238Z</creation></dates><accession>S-EPMC8183414</accession><cross_references><pubmed>33852194</pubmed><doi>10.15252/embr.202050684</doi></cross_references></HashMap>